Early removal of slow-growing brain tumors dramatically improves survival

by Chris Lane,University College LondonGlioma (in centre of image, at top of brainstem). Credit: Wikimedia CommonsA shift in surgical practice over the last decade towards the earlier removal of

Updated on: April 20,2024 14

Early removal of slow-growing brain tumors dramatically improves survival

by Chris Lane,University College LondonGlioma (in centre of image, at top of brainstem). Credit: Wikimedia CommonsA shift in surgical practice over the last decade towards the earlier removal of

Updated on:April 20,2024 14

Genomic variants study points to improved detection of thyroid cancer

by Gabrielle Giroday,University of TorontoCredit: Unsplash/CC0 Public DomainResearchers from Sinai Health and the University of Toronto have gleaned new insights into how thyroid cancer could be

Updated on: July 06,2024 0

Genomic variants study points to improved detection of thyroid cancer

by Gabrielle Giroday,University of TorontoCredit: Unsplash/CC0 Public DomainResearchers from Sinai Health and the University of Toronto have gleaned new insights into how thyroid cancer could be

Updated on:July 06,2024 0

Study pinpoints origin of pediatric brain tumor type and shows it may be preventable

by The Hospital for Sick ChildrenCredit: Unsplash/CC0 Public DomainAn aggressive type of pediatric brain tumor, medulloblastoma, exists in a pre-malignant form at birth after initially developing duri

Updated on: February 18,2024 14

Study pinpoints origin of pediatric brain tumor type and shows it may be preventable

by The Hospital for Sick ChildrenCredit: Unsplash/CC0 Public DomainAn aggressive type of pediatric brain tumor, medulloblastoma, exists in a pre-malignant form at birth after initially developing duri

Updated on:February 18,2024 14

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on: April 12,2024 15

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on:April 12,2024 15

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on: January 11,2024 15

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on:January 11,2024 15

Oncology researchers raise ethics concerns posed by patient-facing artificial intelligence

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainReady or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies

Updated on: April 07,2024 11

Oncology researchers raise ethics concerns posed by patient-facing artificial intelligence

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainReady or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies

Updated on:April 07,2024 11

Blocking a key immune protein improves radiation therapy for cancer

byUniversity of ChicagoCredit: Unsplash/CC0 Public DomainUp to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor re

Updated on: January 22,2024 13

Blocking a key immune protein improves radiation therapy for cancer

byUniversity of ChicagoCredit: Unsplash/CC0 Public DomainUp to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor re

Updated on:January 22,2024 13

ASCT may offer alternative for therapy for high-risk follicular lymphoma

(HealthDay)—Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, accordin

Updated on: March 30,2024 14

ASCT may offer alternative for therapy for high-risk follicular lymphoma

(HealthDay)—Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, accordin

Updated on:March 30,2024 14

Imaging tumor stiffness could help enhance treatment for breast and pancreatic cancer

by Institute of Cancer ResearchKiller T cells surround a cancer cell. Credit: NIHUsing a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about

Updated on: April 07,2024 16

Imaging tumor stiffness could help enhance treatment for breast and pancreatic cancer

by Institute of Cancer ResearchKiller T cells surround a cancer cell. Credit: NIHUsing a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about

Updated on:April 07,2024 16

Overlooked strategy shows promise for treating KRAS-mutated colon cancer

Updated on: June 14,2025 0

Overlooked strategy shows promise for treating KRAS-mutated colon cancer

Updated on:June 14,2025 0

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

by Lori SolomonExclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 inJAMA Network Op

Updated on: March 30,2024 0

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

by Lori SolomonExclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 inJAMA Network Op

Updated on:March 30,2024 0

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on: March 12,2024 17

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on:March 12,2024 17